BioCatalystWatch
MPLTWorkspace / MPLT / OverviewCompany library
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. (MPLT)

Website

Price
Market cap
Next catalystExpected 2H 2027ML-007C-MA — VISTA and open-label extension · Phase 2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

ML-007C-MA

M1 × M4 × peripheral muscarinic receptors

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ML-007C-MA

M1 × M4 × peripheral muscarinic receptors

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

ML-007C-MA

M1 × M4 × peripheral muscarinic receptors

PreINDP1P2P3FilingApproved

History / paused

M1 muscarinic receptor × M4 muscarinic receptor

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MPLT PR & News

PR & News

MPLT SEC archive